Is delta-8 THC really the next big thing?

14th April 2021 - Blog |

From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies and consumers alike. The appeal appears to be that it acts as a “lighter” version of delta-9 […]

What impact will the EC’s decision to permit the use of extracts from the whole plant in cosmetics have on the industry as a whole?

28th January 2021 - Blog |

The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market. Exactly how much of an impact the change – when it eventually is confirmed – will make […]

Do CBD firms expect much of a January uptick in sales?

18th December 2020 - Blog |

It seems many of the firms CBD-Intel has talked to see a similar story for January sales, focused on resolutions or upticks in health and wellness – as was predicted for the holidays sales period stretching from Black Friday at the end of November into the gift-giving Christmas and other holidays period through December. Overall, […]

Topicals report, Q1 2020

16th July 2020 - Market reports |

This report addresses the evolution of the topicals category and the common characteristics and main differences between eight European countries and the US, covering product segmentation and pricing